2 completed. 2 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 2 |
| Phase 3 | 1 | Completed 1 |
Follow Ascariasis: new trials by email Literature Review of Ascariasis trials Research Report on Ascariasis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Efficacy, Safety and Acceptability of Ivermectin ODT in PSAC Ivermectin 1.5 mg ODT, Ivermectin 3 mg Oral Tablet, Albendazole 400 mg Oral Tablet - Trichuriasis, Ascariasis | Phase 2 | Completed | Jennifer Keiser | 260 | 2024-06-05 | 2025-09-22 |
| Efficacy and Safety of MOX/ALB vs. IVM/ALB Co-administration moxidectin (8 mg) / albendazole (400 mg), ivermectin (200 µg/kg) / albendazole (400 mg), ALBENDAZOLE 400 Mg ORAL TABLET [ZENTEL] - Trichuriasis, Ascariasis | Phase 2 / Phase 3 | Completed | Jennifer Keiser | 536 | 2021-03-01 | 2024-12-05 |
Ancylostomiasis (2) · Hookworm Infections (2) · Trichuriasis (2) · Helminthiasis (1) · Intestinal Diseases, Parasitic (1)
Adenophorea Infections (2) · Ascaridida Infections (2) · Enoplida Infections (2) · Infections (2) · Nematode Infections (2) · Parasitic Diseases (2) · Secernentea Infections (2) · Strongylida Infections (2) · Digestive System Diseases (1) · Gastrointestinal Diseases (1) · Helminthiasis (1) · Intestinal Diseases (1)
Albendazole (2) · Ivermectin (2) · Tablets (2) · moxidectin (1)
Jennifer Keiser (2)
Tanzania (2)